Personalized cancer vaccine with radiation therapy
Part of Cancer clinical trials.
This trial tests a personalized cancer vaccine combined with a special type of radiation therapy for people with advanced or recurrent cancers that no longer respond to standard treatments. The goal is to help your immune system better recognize and attack your cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have advanced or recurrent cancer that standard treatments no longer control
- You have at least one tumor that can be measured on scans
- You are able to provide a tumor sample or have DNA data for analysis
- You have a life expectancy of at least 3 months
- You are not pregnant and willing to use contraception
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized vaccine made from unique markers on your tumor cells (called neoantigens). The goal is to help your immune system fight the cancer more effectively. It is for people with advanced solid tumors who have not had gene therapy and are otherwise relatively healthy.
This trial tests a personalized mRNA cancer vaccine (RH125) for people with advanced solid tumors that have spread or cannot be removed by surgery. It may be an option if standard treatments have stopped working or are not suitable, and for some, it will be given with a PD-1 blocker.
This trial tests a personalized vaccine made from your own immune cells (dendritic cells) to help your body fight advanced cancer. It is for people whose cancer has not responded to other treatments.
This trial tests a personalized vaccine made from your own cells to help your immune system attack tumor-specific targets. It may be an option if standard treatments have stopped working or caused side effects you can't tolerate.
This early-phase trial tests a personalized immune treatment made from your tumor’s specific “neoantigen” targets (small pieces the immune system can recognize), plus an immune-boosting medicine. It aims to help control certain cancers by training your immune system to attack your tumor.
This trial tests a personalized vaccine made from “neoantigens” (tumor-specific targets) to help your immune system fight advanced, inoperable solid tumors. It may be an option if standard treatment didn’t work or you stopped it and your health is strong enough for trial treatment.
Hear when a new Advanced Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.